Advances and challenges in the use of nanoparticles to optimize PK/PD interactions of combined anti-cancer therapies. [electronic resource]
- Current drug metabolism 2014
- 818-28 p. digital
Publication Type: Journal Article; Review
1875-5453
10.2174/1389200216666150223152958 doi
Animals Antineoplastic Combined Chemotherapy Protocols--administration & dosage Drug Delivery Systems Drug Design Drug Interactions Drug Liberation Drug Stability Humans Hydrophobic and Hydrophilic Interactions Nanoparticles Neoplasms--drug therapy